Dion Morton

Dion Morton is a leading colorectal surgeon at the University of Birmingham, where he has been Professor of Surgery since 2006. He was appointed Barling Chair of Surgery at the University of Birmingham in 2015. In addition he has served as Director of Clinical Research at the Royal College of Surgeons of England since 2011. In the latter role he has worked to establish a national infrastructure to support the development and dissemination of clinical trials in surgery.[2] He has championed the role of large-scale multi centre randomised controlled trials in informing best practice in surgery.[3]

Professor

Dion Morton
Morton in February 2018
Alma materUniversity of Bristol
Known for
  • West Midlands Research Collaborative[1]
  • Pioneering collaborative research
  • Establishing a national infrastructure for clinical research in surgery
Scientific career
Fields
Institutions
Websitewww.birmingham.ac.uk/staff/profiles/cancer-genomic/morton-dion.aspx

Professor Morton is the Chief Investigator of the 'Fluoropyrimidine, Oxaliplatin and Targeted-Receptor pre-Operative Therapy for patients with high-risk, operable colon cancer' (FOxTROT) trial. This is a groundbreaking trial testing the efficacy of neoadjuvant chemotherapy in colon cancer, a cancer in which neoadjuvant therapy has traditionally had no role.[4]

Professor Morton has pioneered collaborative research in surgery, having championed and closely advised the foundation of the West Midlands Research Collaborative (WMRC), the first trainee-led research network in the UK.[1] Under his guidance the WMRC successfully delivered ROSSINI, the first-ever trainee-led multi-centre randomised controlled trial of a surgical intervention.[5] Subsequent, high-profile ongoing trials have included DREAMS[6] and ROCSS.[7]

He is also regional director of the 100,000 Genomes Project in the West Midlands.[8]

References
  1. http://wmresearch.org.uk/%5B%5D
  2. https://www.rcseng.ac.uk/news/investing-in-surgical-research-2013-the-way-forward-for-leading-healthcare-organisations%5B%5D
  3. https://www.bbc.co.uk/news/health-24388537%5B%5D
  4. http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/coloproctology/foxtrot/index.aspx%5B%5D
  5. Pinkney, T. D; Calvert, M; Bartlett, D. C; Gheorghe, A; Redman, V; Dowswell, G; Hawkins, W; Mak, T; Youssef, H; Richardson, C; Hornby, S; Magill, L; Haslop, R; Wilson, S; Morton, D; West Midlands Research Collaborative; ROSSINI Trial Investigators (2013). "Impact of wound edge protection devices on surgical site infection after laparotomy: Multicentre randomised controlled trial (ROSSINI Trial)". BMJ. 347: f4305. doi:10.1136/bmj.f4305. PMC 3805488. PMID 23903454.
  6. Hamilton, Emma; Ravikumar, Reena; Bartlett, David; Hepburn, Elizabeth; Hwang, Mei-Ju; Mirza, Nazzia; Bahia, Sandeep S; Wilkey, Anthony; Bodenham Chilton, Helen; Handley, Kelly; Magill, Laura; Morton, Dion; West Midlands Research Collaborative (2013). "Dexamethasone reduces emesis after major gastrointestinal surgery (DREAMS)". Trials. 14: 249. doi:10.1186/1745-6215-14-249. PMC 3765230. PMID 23938028.
  7. Bhangu, A; Futaba, K; Patel, A; Pinkney, T; Morton, D (2013). "Reinforcement of closure of stoma site using a biological mesh". Techniques in Coloproctology. 18 (3): 305–308. doi:10.1007/s10151-013-1001-3. PMID 23549713.
  8. http://www.genomicsengland.co.uk/the-100000-genomes-project/%5B%5D


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.